We found that high-risk-score LUAD patients had higher proportions of activated CD4 memory T cells, resting NK cells, M0 macrophages, M1 macrophages, and activated mast cells, confirming that the risk model had a regulatory effect on tumor microenvironments. The gene discussed is CD4; the disease is neoplasm.